EconPapers    
Economics at your fingertips  
 

Microglia alter sex-specific cerebellar myelination following placental hormone loss

Jacquelyn Salzbank, Helene Lacaille, Jenah Gaby, Jiaqi J. O’Reilly, Michael Kissner, Claire-Marie Vacher and Anna A. Penn ()
Additional contact information
Jacquelyn Salzbank: New York-Presbyterian Morgan Stanley Children’s Hospital
Helene Lacaille: New York-Presbyterian Morgan Stanley Children’s Hospital
Jenah Gaby: New York-Presbyterian Morgan Stanley Children’s Hospital
Jiaqi J. O’Reilly: National Institutes of Health
Michael Kissner: Columbia University Medical Center
Claire-Marie Vacher: New York-Presbyterian Morgan Stanley Children’s Hospital
Anna A. Penn: New York-Presbyterian Morgan Stanley Children’s Hospital

Nature Communications, 2025, vol. 16, issue 1, 1-17

Abstract: Abstract Placental dysfunction is linked to neurodevelopmental disorders, with males showing greater vulnerability to perinatal inflammation-mediated brain injuries. Using our transgenic mouse model, Akr1c14cyp19aKO (plKO), we investigate how reduced placental allopregnanolone (ALLO), an anti-inflammatory neurosteroid, contributes to sex-specific brain injury. plKO mice display sex-divergent cerebellar myelination and male-specific autism-like behaviors. Here we show that placental ALLO insufficiency triggers sex-divergent neuroinflammatory responses and microglial dysfunction. Sex-divergent differential expression of inflammatory genes and distinct inflammatory cytokine/chemokine patterns are seen in the placenta and the brain. Prostaglandin E2 (PGE2)-EP4 signaling is identified as a key regulator and, consistent with male plKO cerebellar hypermyelination, male microglial myelin phagocytosis is impaired by SIRPα-CD47 signaling changes. Postnatal manipulation of these critical pathways can normalize cerebellar myelin content and rescue abnormal behavior in male plKO mice. Sex-divergent microglial dysfunction and prostaglandin signaling drive male-biased neurodevelopmental impairments in our model, suggesting new therapeutic targets to improve brain development following placental dysfunction.

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-025-64814-z Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-64814-z

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-025-64814-z

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-11-09
Handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-64814-z